CoChat

Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits

Sun, Hao-Lun, Chen, Si-Han, Yu, Zhong-Yuan, Cheng, Yuan, Tian, Ding-Yuan, Fan, Dong-Yu, He, Chen-Yang, Wang, Jun, Sun, Pu-Yang, Chen, Yang, Tan, Cheng-Rong, Wang, Jun-Ping, Song, Weihong, Zhou, Hua-Dong, Chen, Xiao-Wei, Hu, Zhi-An, Bu, Xian-Le, Wang, Yan-Jiang · 2021 · Molecular Psychiatry

The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.

Abstract

It is traditionally believed that cerebral amyloid-beta (Aβ) deposits are derived from the brain itself in Alzheimer's disease (AD). Peripheral cells such as blood cells also produce Aβ. The role of peripherally produced Aβ in the pathogenesis of AD remains unknown. In this study, we established a bone marrow transplantation model to investigate the contribution of blood cell-produced Aβ to AD pathogenesis. We found that bone marrow cells (BMCs) transplanted from APPswe/PS1dE9 transgenic mice into wild-type (Wt) mice at 3 months of age continuously expressed human Aβ in the blood, and caused AD phenotypes including Aβ plaques, cerebral amyloid angiopathy (CAA), tau hyperphosphorylation, neuronal degeneration, neuroinflammation, and behavioral deficits in the Wt recipient mice at 12 months after transplantation. Bone marrow reconstitution in APPswe/PS1dE9 mice with Wt-BMCs at 3 months of age reduced blood Aβ levels, and alleviated brain Aβ burden, neuronal degeneration, neuroinflammation, and behavioral deficits in the AD model mice at 12 months after transplantation. Our study demonstrated that blood cell-produced Aβ plays a significant role in AD pathogenesis, and the elimination of peripheral production of Aβ can decrease brain Aβ deposition and represents a novel therapeutic approach for AD.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41380-020-0842-1

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Cited by

See all 56

Metadata

Authors
Sun, H.-L., Chen, S.-H., Yu, Z.-Y., Cheng, Y., Tian, D.-Y., Fan, D.-Y., He, C.-Y., Wang, J., Sun, P.-Y., Chen, Y., Tan, C.-R., Wang, J.-P., Song, W., Zhou, H.-D., Chen, X.-W., Hu, Z.-A., Bu, X.-L., & Wang, Y.-J.
Affiliations
  • Army Medical University (CN)
  • University of British Columbia (CA)
Corresponding author
  • Bu, Xian-Le
  • Wang, Yan-Jiang
Venue
Molecular Psychiatry
Published
2020-07-17
Volume
26
Issue
10
Pages
5568-5577
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W3043473142
Cited by
56
References
49
Citations by year
2026: 6 · 2025: 11 · 2024: 11 · 2023: 13 · 2022: 9 · 2021: 3 · 2020: 3
FWCI
4.22
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81625007, 91749206, 31921003, 81930028, 81701043)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
amyloid-beta, blood cells, bone marrow transplantation, Alzheimer's disease pathogenesis, APPswe/PS1dE9 transgenic mice, cerebral amyloid angiopathy, tau hyperphosphorylation, neuroinflammation, neurodegeneration, behavioral deficits, bone marrow reconstitution, therapeutic target
MeSH terms
Alzheimer Disease, Animals, Blood Cells, Brain, Disease Models, Animal, Mice, Transgenic, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits. https://app.cochat.ai/papers/10.1038/s41380-020-0842-1
The paper
Sun, H.-L., Chen, S.-H., Yu, Z.-Y., Cheng, Y., Tian, D.-Y., Fan, D.-Y., He, C.-Y., Wang, J., Sun, P.-Y., Chen, Y., Tan, C.-R., Wang, J.-P., Song, W., Zhou, H.-D., Chen, X.-W., Hu, Z.-A., Bu, X.-L., & Wang, Y.-J. (2021). Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits. Molecular Psychiatry. https://doi.org/10.1038/s41380-020-0842-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.